On September 25, 2026, the Department of Justice announced that it reached a $3,088,605 settlement with United Abrasives, Inc. (“United Abrasives”), the Connecticut-based subsidiary of SAIT Finanziaria S.p.A. (“SAIT”), a company headquartered in Italy, to resolve allegations from Gregg Shapiro’s whistleblower client that United Abrasives improperly obtained a $1,983,555 second draw Paycheck Protection Program loan. . . .
Blog
Gregg Shapiro Represents Whistleblower in $3 Million PPP Qui Tam Settlement with Trax Retail
On September 17, 2026, the Department of Justice announced that it had reached a $3,016,750 settlement with Trax Retail, Inc. (“Trax Retail”), the United States subsidiary of a Singapore company, Trax Technology Solutions Pte. Ltd. (“Trax Technology”), to resolve allegations from Gregg Shapiro’s whistleblower client that Trax Retail improperly obtained a $2,000,000 second draw Paycheck . . .
D.C. Circuit Joins Fourth and Second Circuits In Rejecting Pharma Argument That AKS Implicitly Incorporates A “Corruption” Element
On September 4, 2026, the D.C. Circuit affirmed a summary judgment ruling for the government in a case where Vertex Pharmaceuticals had challenged an unfavorable HHS-OIG advisory opinion. Vertex Pharmaceuticals Inc. v. HHS, No. 25-2133 (D.C. Cir. Sept. 4, 2026). Vertex had sought the advisory opinion for a program that would offer its federally-insured sickle . . .
Tactile Systems Technology Settles Whistleblower Lawsuit Alleging Submission Of False Medicare Claims For Medically Unnecessary Pneumatic Compression Devices
On July 14, 2026, the Department of Justice announced that it had reached a $550,959 settlement with Tactile Systems Technology, Inc. (“Tactile”), to resolve allegations from whistleblowers that Tactile submitted claims to Medicare seeking reimbursement for medically unnecessary pneumatic compression devices, which are used to treat lymphedema and chronic venous insufficiency. Gregg Shapiro represented the . . .
Ninth Circuit 340B Decision Opens Up Whole New World Of Potential Qui Tam Cases
On March 17, 2026, in United States ex rel. Adventist Health System of West v. AbbVie Inc., the United States Court of Appeals for the Ninth Circuit ruled that a 340B covered entity could pursue a False Claims Act qui tam case against drug companies that charged covered entities more than the 340B ceiling price . . .
Read More from Ninth Circuit 340B Decision Opens Up Whole New World Of Potential Qui Tam Cases
Gregg Shapiro Represents Whistleblower in $1.8 Million PPP Qui Tam Settlement with Swiss Fashion House Akris
On January 22, 2026, the Department of Justice announced that it had reached a $1,823,100 settlement with Akris, Inc. (“Akris”), the United States subsidiary of Swiss fashion house Akris AG, to resolve allegations from Gregg Shapiro’s whistleblower client that Akris improperly obtained a $1,118,000 second draw Paycheck Protection Program loan. Gregg filed the whistleblower’s False . . .
Eugenie Reich & Gregg Shapiro Announce $15 Million False Claims Act Grant Fraud Settlement With Dana-Farber
On December 16, 2025, the U.S. Department of Justice announced that it had reached a $15 million settlement with Dana-Farber Cancer Institute to resolve False Claims Act allegations that Dana-Farber researchers relied on inaccurate biological images to win NIH grants. Eugenie Reich and her co-counsel Gregg Shapiro filed a False Claims Act qui tam complaint . . .
Gregg Shapiro Represents Whistleblower in $2.1 Million PPP Qui Tam Settlement with Hitachi Subsidiary
On December 12, 2025, the Department of Justice announced that it had reached a $2,092,371.92 settlement with KOKUSAI DENKI Electric America, Inc., formerly known as Hitachi Kokusai Electric Comark, LLC (“Hitachi Comark”), to resolve allegations from Gregg Shapiro’s whistleblower client that Hitachi Comark fraudulently obtained a $1,342,232 second draw Paycheck Protection Program loan. Gregg filed . . .
In Summary Judgment Decision, Court Finds That Relator Satisfied But-For Causation Standard
In an important development in the emerging body of caselaw on the application of the “but-for” causation standard to False Claims Act cases predicated on alleged violations of the anti-kickback statute, the court in United States ex rel. Witkin v. Medtronic, Inc., No. 1:11-cv-10790-IT (Nov. 14, 2025, D. Mass.), has once again denied Medtronic’s motion . . .
Potential Whistleblower Opportunities Under The Massachusetts False Claims Act
The Office of the Massachusetts Attorney General (“AGO”) has long been one of the nation’s leaders in pursuing False Claims Act cases at the state level. The AGO’s Medicaid Fraud Division and False Claims Division both have relatively new leaders – Kevin Lownds and Colleen Nevin, respectively – and their recent statements suggest that the . . .
Read More from Potential Whistleblower Opportunities Under The Massachusetts False Claims Act